Savvyn, PBC
About Savvyn, PBC
Savvyn is a platform for evidence intelligence for life sciences. It provides a platform to schedule a call and ensures patient impact. Built for Medical Affairs, Market Access, and early founding teams, it addresses the evidence lifecycle from scoping indications to appealing denials. The platform claims 99.4% citation traceability and a 0.8% hallucination rate, with 673 corpus elements validated under a Maine Technology Institute feasibility grant.
Investors
Not disclosed in the source filing. Form D filings do not list investors — StreetZero surfaces them from news where available.
Key highlights
- Raised $50,000 in a private placement with undisclosed investors.
- Platform delivers 99.4% citation traceability and 0.8% hallucination rate.
- Headcount of 3 employees as of latest data.
- Validated 673 corpus elements via Maine Technology Institute grant.
- Targets Medical Affairs and Market Access teams in healthcare.
Ask StreetZero about Savvyn, PBC
Put our AI to work on this deal.
Similar companies
Other Other Technology deals, ranked by Signal.
Source document & SEC filing
The source SEC filing and the cached document are available to members only. Sign in to view and download them.
Sign in to view the filing Create free account